Antimicrobial Susceptibility Testing MarketSize, Share & Industry Analysis, 2026-2034By Product TypeBy Test Method / TechnologyBy Organism Type TestedBy ApplicationBy Sample/specimen TypeBy End UserBy Testing Site / Care SettingBy Distribution ChannelBy Testing Standard / Breakpoint Guideline
Full title & scope — all 9 axes with their segments
Antimicrobial Susceptibility Testing Market Size, Share & Industry Analysis, By Product Type (Automated & Semi-Automated AST Instruments, Reagents & Consumables, Manual & Non-Automated Instruments, Software & Data Management Systems, Testing Services), By Test Method / Technology (Disk Diffusion, Broth Microdilution / Macrodilution, Agar Dilution, Gradient Diffusion, Automated Broth Microdilution Systems, Genotypic / Molecular AST, MALDI-TOF MS-Based AST), By Organism Type Tested (Antibacterial Susceptibility Testing, Antifungal Susceptibility Testing, Antiviral Susceptibility Testing, Antiparasitic Susceptibility Testing), By Application (Clinical Diagnostics, Drug Discovery & Antimicrobial Development, Epidemiological & AMR Surveillance, Food, Water & Environmental Testing, Veterinary & Animal Health Testing), By Sample/specimen Type (Blood & Blood Culture, Urine, Respiratory Specimens, Wound, Tissue & Pus, Stool, Cerebrospinal & Other Sterile Body Fluids), By End User (Hospital & Clinical Laboratories, Independent Reference & Commercial Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Public Health & Government Agencies), By Testing Site / Care Setting (Centralized/Reference Laboratory Testing, Point-of-Care & Near-Patient Testing, Decentralized On-Site Hospital Lab Testing), By Distribution Channel (Direct Sales, Third-Party Distributors, Group Purchasing Organizations, Online/E-Procurement Platforms), By Testing Standard / Breakpoint Guideline (CLSI-Based Testing, EUCAST-Based Testing, Other National/Regional Standards), and Regional Forecast, 2026-2034
Segment definitions and share of revenue by product, animal, end user and region.
Segmentation Analysis
9 axesBy Product Type
5- 01Automated & Semi-Automated AST Instruments
- 02Reagents & Consumables
- 03Manual & Non-Automated Instruments (Incubators, Readers)
- 04Software & Data Management Systems
- 05Testing Services
By Test Method / Technology
7- 01Disk Diffusion (Kirby-Bauer)
- 02Broth Microdilution / Macrodilution
- 03Agar Dilution
- 04Gradient Diffusion (Etest)
- 05Automated Broth Microdilution Systems
- 06Genotypic / Molecular AST
- 07MALDI-TOF MS-Based AST
By Organism Type Tested
4- 01Antibacterial Susceptibility Testing
- 02Antifungal Susceptibility Testing
- 03Antiviral Susceptibility Testing
- 04Antiparasitic Susceptibility Testing
By Application
6- 01Clinical Diagnostics
- 02Drug Discovery & Antimicrobial Development
- 03Epidemiological & AMR Surveillance
- 04Food
- 05Water & Environmental Testing
- 06Veterinary & Animal Health Testing
By Sample/specimen Type
7- 01Blood & Blood Culture
- 02Urine
- 03Respiratory Specimens (Sputum/BAL)
- 04Wound
- 05Tissue & Pus
- 06Stool
- 07Cerebrospinal & Other Sterile Body Fluids
By End User
5- 01Hospital & Clinical Laboratories
- 02Independent Reference & Commercial Laboratories
- 03Academic & Research Institutes
- 04Pharmaceutical & Biotechnology Companies
- 05Public Health & Government Agencies
By Testing Site / Care Setting
3- 01Centralized/Reference Laboratory Testing
- 02Point-of-Care & Near-Patient Testing
- 03Decentralized On-Site Hospital Lab Testing
By Distribution Channel
4- 01Direct Sales
- 02Third-Party Distributors
- 03Group Purchasing Organizations (GPOs)
- 04Online/E-Procurement Platforms
By Testing Standard / Breakpoint Guideline
3- 01CLSI-Based Testing
- 02EUCAST-Based Testing
- 03Other National/Regional Standards
Segment categories shown for scope reference. See the Summary tab for revenue share by Product Type. Full segment-by-segment detail across every axis is available in the sample and full report.
Questions This Report Answers
6 questionsWhat is the market size and growth rate, globally and by region?
How is the market segmented, and which segments lead?
Which regions and countries are covered, and how do they compare?
What are the key drivers, restraints, opportunities and challenges?
Who are the leading companies operating in this market?
What trends are expected to shape the market through the forecast period?
Frequently Asked Questions
01What is the Antimicrobial Susceptibility Testing Market projected to reach?
USD 9.68 USD Billion by 2034, CAGR 8.5%
02What years does this report cover?
Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.
03Which regions are covered?
North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
04Which region accounted for the largest market share?
North America leads with 40.2% of global revenue through 2034.
05Which segment leads the market?
Reagents & Consumables is the largest line by product type, at 38.1% of revenue in 2025.
06Who are the key companies profiled?
bioMérieux SA, Becton, Dickinson and Company (BD), Danaher Corporation (Beckman Coulter / Cepheid), Remel / Oxoid (formerly Thermo Fisher Scientific Microbiology, now an independent Astorg portfolio company), Bruker Corporation, QIAGEN N.V., Accelerate Diagnostics, Inc., T2 Biosystems, Inc., Bio-Rad Laboratories, Inc., Merck KGaA (MilliporeSigma), Roche Diagnostics (F. Hoffmann-La Roche Ltd), Hardy Diagnostics, Liofilchem S.r.l., Alifax S.r.l., HiMedia Laboratories Pvt. Ltd., Creative Diagnostics, Selux Diagnostics, Inc., Autobio Diagnostics Co., Ltd., Werfen (Instrumentation Laboratory), Rapid Micro Biosystems, Inc., Diatron MI Zrt., Neogen Corporation, Abbott Laboratories, Coris BioConcept. Full profiles are part of the paid report.
07Can the segmentation be customized?
Yes. Custom data cuts by geography, segment, or competitor set are available on request.
Why choose CDI
Need this report shaped around your question?
The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.
Most licences include 30–60 hours of customization at no extra cost. See what each licence includes
Additional Companies
Add competitors, suppliers or the peer set you benchmark against to the companies already covered.
Deeper Competitive View
Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.
Extra Segment Splits
Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.
Application Focus
Narrow the analysis to the specific use cases and end users your team actually sells into.
Different Time Frame
Move the base year, or widen the historical and forecast windows the study is built on.
Country-Level Detail
Go below region level into the individual countries that matter to you, rather than the standard geography split.